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Central nervous system (CNS) tumors are common. In recent years, with
the continuous development and popularization of neurosurgery and
the advancement of diagnostic and therapeutic instruments, the
diagnosis and treatment of diseases have made great progress, but the
prognosis of patients depends on multiple clinical factors. In this study,
we selected various literatures in the PubMed and Google Scholar search
engines using the keywords “nerve repair strategies”, “central nervous
system tumor” as well as searched scientifically reviewed historical
perspectives and recent advancements and achievements in
Neurorestoratology of the CNS. Therefore, this study focuses on the
Neurorestoratology of the CNS and its prospects, aiming to provide
scientific guidance for the clinical diagnosis and treatment of CNS
tumors in the future, and improve the prognosis and quality of life of
patients.

© The authors 2020. This article
is published with open access at
http://jnr.tsinghuajournals.com
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Introduction

For a long time, it has been believed that the
hardware of the brain is indeed hard and that
once an incident such as a central nervous
system (CNS) tumor occurs, brain structure and
function will be lost forever. CNS tumors are
one of the most serious CNS injuries. Most
patients with CNS tumors are unable to live
independently or take care of themselves, which
imposes a huge burden on their families and the
society. In 2016, a total of 329,673 new cancers
occurred globally, with an age‐adjusted
incidence of 4.63 per 100,000 person‐years, a

significant increase of 17.3% between 1990 and
2016. In 2016, there were 227,039 deaths from
CNS cancer worldwide, with an age‐
standardized mortality rate of 3.24 per 100,000
person‐years, and there was no significant
change in mortality from 1990 to 2016 [1], which
was higher in males than that in females, and
was mostly thorax or cervix related [2–6]. In
recent years, with the establishment and populariza‐
tion of the science of Neurorestoratology, which
is a branch of neuroscience that studies nerve
regeneration, repair or replacement of nerve
structure, nerve remodeling, and nerve
regulation, aiming to promote the reconstruction

Corresponding author: Jinquan Cai, Email: caijinquan666777@126.com

Journal of Neurorestoratology

and recovery of nerve function in various
neurodegenerative diseases and damages. The
traditional viewpoint, which is still popular in
the medical community, is that there is currently
no effective treatment to completely, or even
partially restore neurological functions lost due
to intractable CNS damage or disease. Thus,
current nerve repair strategies (NRS) only
achieve limited partial or moderate recovery.
However, these achievements are more than
enough to answer the question of whether
patients with intractable CNS damage or disease
could benefit from various clinical NRS such as
cell therapy, neurostimulation or neuromodula‐
tion, neuroprosthesis, or related advanced
assistive devices, nerve bridging, neurorehabilita‐
tion, drug or growth factors, and other novel
treatment procedures [7–10]. In this review, we
discuss the treatment of tumor‐induced injury of
the CNS, including commonly used nursing and
drugs. We also discuss some novel approaches
such as cell therapy and neuroprotectants, and
discuss the limitations of current therapies and
the future direction of treatment.

Fig. 1

Flow diagram of literature and screen strategy.
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Methods

We performed a search of the PubMed and
Google Scholar databases since 1995 for
peer‐reviewed papers published in the English
language using the keywords “nerve repair
strategies”, “central nervous system tumor”, cell
therapy, and neural prostheses, all of which
display the historical events and recent main
advancements and achievements. Also, meeting
abstracts, case reports, and editorials were
excluded from our review. The authors reviewed
all the titles and abstracts independently, and
screened them according to the inclusion criteria.
All the references of included literature were
also screened systematically. Original papers
reporting a definitive intervention in a stated
number of patients were included in the
analysis. In the case of two or three publications
emanating from one study, the version with the
longest follow‐up period and most complete
reporting was included. All the included studies
had been approved by local institutional review
boards. The flow chart is shown in Fig. 1.
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Results and discussion

There are two main types of CNS damage:
primary injury, including neural cell damage
and vascular destruction; and secondary injury,
including inflammation, excitotoxicity, edema,
ischemia, chronic demyelination, and the
formation of glial scars, etc., which causes
apoptosis and aggravates damage [11, 12]. CNS
damage or disease could be treated by various
clinical NRS, such as cell therapy, neurostimula‐
tion or neuro modulation, neuroprosthesis or
related advanced assistive devices, bioengineer‐
ing or tissue engineering, neurotization or nerve
bridging, neurorehabilitation, drug or growth
factors, and other novel therapeutic procedures.
3.1

Pharmacotherapy

3.1.1 Melatonin
Reiter et al. [13] reported that melatonin’s
actions in organisms are more widespread than
originally envisaged, which has been linked to
circadian rhythms, immune function, sleep,
retinal physiology, and endocrine function in
general. In in vivo trials, the pharmacological
dose of melatonin has been found to be effective
in reducing the macromolecular damage that is
the consequence of free radical generation
induced by a variety of toxic agents, exogenous
organisms and experimental paradigms. The
lack of toxicity of melatonin and the ease of
crossing morphophysiological barriers and
entering subcellular compartments are essential
features of neurorestoration. In a recent study,
all the results suggested that melatonin could
reduce nerve cell death and cerebral damage,
and the effect of a caudal vein injection was
better than that of an intraperitoneal injection.
This may be associated with the drug levels of
the areas with brain injury [14].
3.1.2 Mecobalamin
Matsushita et al. [15] reported that mecobalamin,

a coenzyme of vitamin B12, promotes the
metabolism of nucleic acids, proteins, and lipids
via a methyl conversion reaction. Mecobalamin
readily enters nerve tissues and promotes the
restoration of injured nervous tissue. Mecobalamin
significantly upregulates growth associated
protein 433 mRNA levels in nervous tissue after
sciatic nerve injury. Mecobalamin promotes
functional and morphological recovery after
nerve injury. The molecular mechanism underly‐
ing the restorative effects of mecobalamin on
injured nerves may involve upregulation of the
genes for multiple neurotrophic factors [16].
3.1.3

Ganglioside

Geisler et al. [17] reported that ganglioside did
not demonstrate any significant differences
between the treatment group and the control
group in a multicenter randomized, double‐
blind, and placebo‐control clinical trial; as such,
ganglioside is not recommended as a routine
therapy in CNS damage. However, according to
Gusheng Wu [18], who reported that ganglioside
is widely used in the nervous system and plays
an important role in the recovery of nervous
system function. Therefore, whether or not
ganglioside plays a role in the recovery of
nervous system injury needs further exploration.
3.1.4

Metformin

Insulin resistance influences ATP production
emission in neurons and astrocytes, as well as
mixed‐glial cultures [19]. The effect of metfor‐
min on cognition is clinically controversial, and
observational studies have shown no clear effect
[20]; however, it is likely to be associated with
high metformin‐induced vitamin B12 deficiency
[21], and causes cognitive deficiency [22].
Although it has been found in recent research
developments that metformin reverses brain
mitochondrial function, they showed that
insulin resistance caused significant impairment
Journal of Neurorestoratology
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of brain mitochondrial function, which is
mitigated by metformin, thereby restoring
neurological function [23].
3.2

Nerve repair surgery

3.2.1 Nerve transplantation
Vascular bundle implantation can rapidly
reconstruct the blood supply of the nerve
segment compressed by the tumor of the
nervous system, which can significantly
promote nerve regeneration and functional
recovery [24]. The authors’ threshold for
adequate nerve health is at least 75%
preservation of fascicular architecture [25, 26].
The two weeks following nerve injury is the best
time for nerve repair [27]. The vascular bundle is
extracted by the chemical method to cell
allogeneic nerve preservation of the basement
membrane tube, which has an instructive effect
to promote the regeneration of nerve fibers [28].
More experts started to perform similar surgical
procedures and showed partial neurological
functional improvements [29–32].
3.2.2

Nerve decompression

Nerve decompression involves the removal of
tumors and the muscles that compress the nerve.
For example, in patients with acoustic neuroma
or trigeminal neuralgia, the nerves are
compressed, and it is necessary to remove the
compression surgically [33]. An acoustic
neuroma results from an overproduction of
Schwann cells (myelin sheath‐producing cells)
on the vestibulocochlear nerve [34, 35]. As the
tumor grows, it compresses nearby nerves, such
as the cochlear or vestibular nerve, against the
bony auditory canal. This compression leads to
hearing loss and balance issues. If tumor growth
extends outside the auditory canal, additional
cranial nerves would be at risk for compression,
including the trigeminal nerve and the facial
nerve [36]. As a tumor enlarges, it displaces
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surrounding brain structures. Other CNS tube
tumors and acoustic neuromas are the same.
After surgical treatment, the symptoms of
compression are alleviated, and most of the
nerve function can be restored [37–39].
3.2.3

Other

The patient can choose stereotactic radiosurgery,
but it does not work fast enough. Decisions
about treatment are based on patient factors,
such as physical condition, willingness to
receive treatment, curability of the lesion with
radiation, and so on [40].
3.3

Nursing intervention

3.3.1 Nursing
Nursing is divided into perioperative nursing
and postoperative nursing. As surgical removal
is the best treatment option, the patient needs a
perioperative continuum of care, but postopera‐
tive care is more important for the recovery of
neurological function. Effective nursing interven‐
tion measures can promote recovery of the
neurological function of patients, improve their
cognitive function, improve postoperative quality
of life, and prolong their survival time [41].
3.3.2

Physical activity

Physical activity is effective as a rehabilitation
tool for recovery and promoting neurological
functional [42, 43]. Indeed, it was found that
physical training not only promoted cerebral
angiogenesis, vasomotor reactivity, and neurotro‐
phic factor release; but also reduced apoptosis
and excitotoxicity, and could improve the
regulation of motor unit activation [44–47].
3.4

Hyperbaric oxygen therapy

Although surgical resection of tumors can
improve the clinical symptoms and relieve the
pain of patients, the incidence of postoperative
cerebral edema is extremely high. Edema and
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compression can easily cause visual and
neurological damage, which would seriously
affect the outcome of surgery and prognosis of
patients [39]. Its occurrence is mainly due to the
preoperative compression of the tumor tissue of
the nervous system, resulting in hypoxia and
edema of the tissue surrounding the brain
tumor, and the brain edema still exists after the
resection of the tumor [48]. Hyperbaric oxygen
will promote the survival of surrounding tissues,
reduce edema, improve microcirculation, break
the edema-hypoxia-edema vicious cycle, promote
healing, promote the up‐regulation of growth
factors, and improve neovascularization. Timing
is also important. The treatment time for acute
nerve injury is approximately 6 hours. If
hyperbaric oxygen therapy begins after this time
window, it may also have a negative effect on
the tissues. It was found that hyperbaric oxygen,
if administered early, promotes nerve repair,
regeneration, and functional recovery as early as
10 days after injury. The effect persisted after 14
weeks, suggesting that it was not a short‐term
effect. Also, studies have shown that hyperbaric
oxygen can enhance the vitality of Schwann cells
while improving microcirculation, and Schwann
cells play an important role in nerve tissue
regeneration [49–52].
3.5

Other methods

3.5.1 Music treatment
During the past years, subjective experiences of
the emotional and cognitive impact of music
have received increasing experimental and
scientific support that music evokes strong
emotions [53], influencing our autonomic
nervous and neuroendocrine systems [54],
enhances cognitive functioning [55], and
activates the brain extensively, engaging
multiple temporal, frontal, parietal, cerebellar,
and limbic regions [56]. Similarly, in response to
the growing prevalence of many aging‐related

severe neurological conditions, many music‐
based rehabilitation methods have been
developed to enhance recovery or sustain
functioning in the cognitive, motor, language,
emotional, or social domain [57].
3.5.2

Rehabilitation treatment

Shi et al. [58] reported that rehabilitation
training can individually and synergistically
improve the recovery of neurological function
and motor function after cerebral ischemic
injury.
Therefore,
rehabilitation
requires
comprehensive treatment, and parents and
rehabilitation workers are still looking forward
to finding more treatments [59].
3.5.3

Acupuncture

Acupuncture is a form of alternative medicine
that has been commonly used to relieve
symptoms in the Chinese medical system for
more than 2000 years [60]. Yu et al. [61] reported
that acupuncture was helpful in the neurorestora‐
tion of CNS tumor damage. Many rehabilitation
hospitals offer acupuncture in China.
3.5.4

Neuroprotectants

In the past 50 years, more than 1,000 drugs have
been expected to improve neuropathy after
acute ischemic stroke (AIS), but none of them
has been recognized by the academic community.
Na‐1 is the first drug demonstrated to have a
neuroprotective effect after AIS. It maintains
neural activity by blocking the production of
nitric oxide (NO) by cells in an anoxic
environment. Researchers did not rush to the
clinic with such a positive result, but there is no
doubt that the first positive result for a drug in
nearly 50 years must have surprised the medical
world [62].
3.6

Novel treatment

Novel treatment methods are mainly embodied
Journal of Neurorestoratology
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in cell therapy. Cell therapy is well known as the
most promising treatment in regenerative
medicine. Embryonic stem cells, induced
pluripotent stem cells, neural stem cells, and
other functional cells such as Schwann cells
have demonstrated their effectiveness in
treating certain diseases. However, these cell
groups face barriers in cell source, ethics,
tumorigenicity, or limited functional recovery
[63–65].
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